HHS Awards $90M for COVID-19 Research to ABT Global LLC under Full and Open Competition

Contract Overview

Contract Amount: $89,948,062 ($89.9M)

Contractor: ABT Global LLC

Awarding Agency: Department of Health and Human Services

Start Date: 2020-05-19

End Date: 2023-09-30

Contract Duration: 1,229 days

Daily Burn Rate: $73.2K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: COST PLUS FIXED FEE

Sector: R&D

Official Description: COVID-19 RESEARCH IN REPONSE TO BAA POSTING

Place of Performance

Location: CAMBRIDGE, MIDDLESEX County, MASSACHUSETTS, 02138

State: Massachusetts Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $89.9 million to ABT GLOBAL LLC for work described as: COVID-19 RESEARCH IN REPONSE TO BAA POSTING Key points: 1. Contract value of $89.9M awarded for COVID-19 research. 2. Competition was full and open, indicating a competitive bidding process. 3. Risk appears moderate given the research and development nature of the contract. 4. The sector is R&D, specifically physical, engineering, and life sciences.

Value Assessment

Rating: fair

The contract type is Cost Plus Fixed Fee, which can lead to higher costs if not managed carefully. The award amount is substantial for R&D, but without specific benchmarks for similar COVID-19 research projects, a precise value assessment is difficult.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, suggesting multiple vendors had the opportunity to bid. This method generally promotes price discovery and competitive pricing.

Taxpayer Impact: Taxpayer funds are being used for critical COVID-19 research, with the potential for significant public health benefits. The competitive award process aims to ensure efficient use of these funds.

Public Impact

Funding supports vital research into COVID-19, potentially leading to new treatments or understanding of the virus. The contract duration of over 3 years suggests a long-term commitment to research efforts. Transparency in the award process through full and open competition is a positive for public trust.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

This contract falls within the Research and Development sector, specifically focusing on physical, engineering, and life sciences. Spending in this area is crucial for scientific advancement and addressing public health crises like COVID-19.

Small Business Impact

The data does not indicate whether small businesses were involved in this contract, either as prime contractors or subcontractors. Further analysis would be needed to determine small business participation.

Oversight & Accountability

The Centers for Disease Control and Prevention (CDC) is responsible for overseeing this contract. Standard government oversight mechanisms for R&D contracts would apply, including progress reports and financial reviews.

Related Government Programs

Risk Flags

Tags

research-and-development-in-the-physical, department-of-health-and-human-services, ma, definitive-contract, 10m-plus

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $89.9 million to ABT GLOBAL LLC. COVID-19 RESEARCH IN REPONSE TO BAA POSTING

Who is the contractor on this award?

The obligated recipient is ABT GLOBAL LLC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Centers for Disease Control and Prevention).

What is the total obligated amount?

The obligated amount is $89.9 million.

What is the period of performance?

Start: 2020-05-19. End: 2023-09-30.

What specific research objectives does this contract aim to achieve, and how will their success be measured?

The contract details do not specify the precise research objectives or key performance indicators for this COVID-19 research. Typically, such contracts would outline specific scientific goals, milestones, and deliverables. Measuring success would likely involve evaluating the quality of research findings, adherence to scientific rigor, and the potential impact on understanding or combating COVID-19.

What are the potential risks associated with a Cost Plus Fixed Fee contract for R&D, and how are they mitigated?

A Cost Plus Fixed Fee (CPFF) contract carries the risk of cost overruns, as the contractor is reimbursed for actual costs plus a fixed fee. Mitigation strategies include robust government oversight, detailed cost tracking, clear definition of allowable costs, and performance incentives. For R&D, CPFF can be appropriate when the scope is uncertain, but requires diligent management to control spending.

How does the $89.9 million award compare to typical spending for similar COVID-19 research initiatives?

Without specific benchmarks for comparable COVID-19 research projects, it's challenging to definitively assess if $89.9 million is high or low. However, given the urgency and scale of the pandemic, substantial funding for research was allocated across various agencies. This award appears to be a significant investment, suggesting a comprehensive research scope or a multi-year effort.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesScientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENTN – Health R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: 75D301-20-R-67987

Offers Received: 1

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Address: 6130 EXECUTIVE BLVD, ROCKVILLE, MD, 20852

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, Subchapter S Corporation, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $89,948,062

Exercised Options: $89,948,062

Current Obligation: $89,948,062

Actual Outlays: $80,947,654

Subaward Activity

Number of Subawards: 63

Total Subaward Amount: $52,334,935

Contract Characteristics

Multi-Year Contract: Yes

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Timeline

Start Date: 2020-05-19

Current End Date: 2023-09-30

Potential End Date: 2023-09-30 00:00:00

Last Modified: 2024-06-07

More Contracts from ABT Global LLC

View all ABT Global LLC federal contracts →

Other Department of Health and Human Services Contracts

View all Department of Health and Human Services contracts →

Explore Related Government Spending